BridgeMD
Compares treatment options for Preoperative Anxiety
Official title Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery
ClinicalTrials.gov ID: NCT06489327
What this study is testing
What is melatonin (Circadin ®) 0.2 mg/kg?
melatonin (Circadin ®) 0.2 mg/kg is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for preoperative anxiety.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Preoperative anxiety is a common issue in pediatric anesthesia. Children often experience anxiety and uneasiness due to uncertain outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 10
You may be able to join if
- Patients of either sex
- age from 4 to 14 years
- Patients with American society Anesthesiologist physical status I and II
- Patients undergoing elective surgeries
You likely can't join if
- ASA more than III
- Drug allergy.
- Gastrointestinal disorders.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
- Madīnat Bābil, Babel, Iraq
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 10 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt; Madīnat Bābil, Babel, Iraq. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.